Evidence map›Paper›PMID 27630165›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2016

Long-Lived CD4+IFN-γ+ T Cells rather than Short-Lived CD4+IFN-γ+IL-10+ T Cells Initiate Rapid IL-10 Production To Suppress Anamnestic T Cell Responses during Secondary Malaria Infection.

Ana Villegas-Mendez, Colette A Inkson, Tovah N Shaw, Patrick Strangward, Kevin N Couper

Open access · hybridAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Lessons Learned for Pathogenesis, Immunology, and Disease of Erythrocytic Parasites:Frontiers in cellular and infection microbiology · 2021
    Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Accelerator or Brake: Immune Regulators in Malaria.Frontiers in cellular and infection microbiology · 2020
    Review
  15. Article
  16. TFrontiers in immunology · 2019
    Review
  17. Recent advances on T-cell exhaustion in malaria infection.Medical microbiology and immunology · 2018
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Ana Villegas-MendezFaculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PT, United Kingdom.
Colette A InksonFaculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PT, United Kingdom.ORCID 0000-0003-1215-312X
Tovah N ShawFaculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PT, United Kingdom.ORCID 0000-0002-8107-2836
Patrick StrangwardFaculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PT, United Kingdom.
Kevin N CouperFaculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PT, United Kingdom kevin.couper@manchester.ac.uk ana.villegas-mendez@manchester.ac.uk.ORCID 0000-0003-4659-8960
Manchester Academic Health Science Centre · GB

Funding

Biotechnology and Biological Sciences Research Council BB/I020950/2Medical Research Council G0900487Medical Research Council MR/L008564/1Medical Research Council MR/L011840/1
6 · The paper itself

Abstract

CD4

Indexed as

Immunologic MemoryAnimalsCD4-Positive T-LymphocytesCells, CulturedCell SurvivalHumansImmunosenescenceInterferon-gammaInterleukin-10Lymphocyte ActivationMalariaMiceMice, Inbred C57BLMice, TransgenicPlasmodiumInterferon-gammaInterleukin-10

Identifiers

PMID27630165
PMCPMC5055201
OpenAlexW2519004769

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.